Open AccessBiosynthesis of Ag, Se, and ZnO nanoparticles with antimicrobial activities against resistant pathogens using waste isolate Streptomyces enissocaesilis
Author(s) -
Shaaban Mona,
ElMahdy Areej M.
Publication year - 2018
Publication title -
iet nanobiotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.366
H-Index - 38
eISSN - 1751-875X
pISSN - 1751-8741
DOI - 10.1049/iet-nbt.2017.0213
Subject(s) - bacillus cereus , antimicrobial , microbiology and biotechnology , staphylococcus aureus , streptomyces , escherichia coli , pseudomonas aeruginosa , klebsiella pneumoniae , chemistry , bacteria , nuclear chemistry , biology , biochemistry , genetics , gene
Nanoparticles (NPs) are gaining special interest due to their recent applications as antimicrobial agents to defeat the massive threat of resistant pathogens. This study focused on the utilisation of Streptomyces isolate S12 purified from waste discharge soil in the biological synthesis of silver (Ag), selenium (Se), and zinc oxide (ZnO) NPs. The isolate S12 was related to Streptomyces enissocaesilis according to 16S rRNA sequence analysis, morphological characteristics, and biochemical reactions. The cell‐free supernatant has been used for the synthesis of Ag, Se, and ZnO NPs. The synthesised NPs were characterised using ultraviolet–visible spectroscopy, dynamic light scattering (DLS), transmission electron microscopy, and Fourier transform infrared spectroscopy. The biogenic NPs were evaluated for antimicrobial effects against different Gram‐positive and Gram‐negative resistant isolates using the broth microdilution method. They showed antibacterial effect against standard and resistant isolates; Bacillus cereus , Staphylococcus aureus ATCC 29213, S. aureus S1.1, methicillin resistant S. aureus (MRSA 303, 402 and 807), Escherichia coli ATCC 12435, E. coli E7, Klebsiella pneumoniae ATCC 51503, K. pneumoniae K5, K112, Pseudomonas aeruginosa PAO1, and P. aeruginosa P8. This study showed the green synthesis of various NPs using Streptomyces isolate S12 which demonstrated diverse activities against multi‐drug resistant isolates.